Skip to content

Robert Iannone, EVP, Global Head of R&D & CMO at Jazz Pharmaceuticals, sold JAZZ on Aug 27, 2026

Data as of Oct 16

▼ SELL$4.5M18,113 shares at $250.02Robert Iannone EVP, Global Head of R&D & CMOJAZZ Jazz Pharmaceuticals plc
Watch JAZZ
Traded
Aug 27, 2026
Disclosed
Aug 31, 2026
Filed
4 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Robert Iannone, EVP, Global Head of R&D & CMO at Jazz Pharmaceuticals, sold JAZZ on Aug 27, 2026TRADEDDISCLOSED
JAZZSimilar stocks (XLV — its sector index fund), rebased to JAZZ's price on the disclosure day
JAZZ since disclosure
−16.1%
after the sale
Similar stocks (XLV) since disclosure
+3.6%
XLV — its sector index fund

Change in closing price from Aug 31, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLRobert Iannone EVP, Global Head of R&D & CMOJAZZ Jazz Pharmaceuticals plc$4.9Mdisclosed Aug 31 · filed 4 days after the trade
  2. ▼ SELLRobert Iannone EVP, Global Head of R&D & CMOJAZZ Jazz Pharmaceuticals plc$2.8Mdisclosed Aug 31 · filed 4 days after the trade
  3. ▼ SELLRobert Iannone EVP, Global Head of R&D & CMOJAZZ Jazz Pharmaceuticals plc$4.5Mdisclosed Aug 31 · filed 4 days after the trade
  4. ▼ SELLRobert Iannone EVP, Global Head of R&D & CMOJAZZ Jazz Pharmaceuticals plc$75.8Kdisclosed Aug 31 · filed 4 days after the trade
  5. ▼ SELLRobert Iannone EVP, Global Head of R&D & CMOJAZZ Jazz Pharmaceuticals plc$2.3Mdisclosed Aug 31 · filed 4 days after the trade

See every trade on JAZZ →